Today

Agents

Chat

Arena

Discover

More

App

Voyager Therapeutics Q2 Net Income USD -24.473 Million - VYGR News | Rallies

Voyager Therapeutics Q2 Net Income USD -24.473 Million

VYGR•2026-08-06

Q2 financial results

Aug. 6 (Reuters) - Voyager Therapeutics Q2 basic EPS USD -0.4.

Q2 collaboration revenue USD 3.165 million
Q2 operating income USD -26.392 million
Q2 pretax profit USD -24.453 million

Related News

Better Home & Finance files initial beneficial ownership statement for interim CEO Daniel Seth Lewis

BETR•2026-08-06

WEX COO, American Payments & Mobility Carlos Carriedo sells 1,075 shares for $199,950

WEX•2026-08-06

DoubleVerify Q2 FY26 net income rises 47% to $12.9 million; revenue increases 3% to $193.8 million

DV•2026-08-06

Valhi Q2 FY26 net income attributable to stockholders rises to $22.3 million; net sales increase 12.2% to $606.1 million

VHI•2026-08-06

Main Street Capital Q2 FY26 net investment income rises 2% to $90.3 million

MAIN•2026-08-06